Clinical Trial Update: Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AMOR-1 for treating hypocalcemia associated with hypoparathyroidism is currently recruiting in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypocalcemia
• Hypoparathyroidism

Drugs mentioned

• AMOR-1

Snippet

Sponsor: Amorphical Ltd. | Conditions: Hypoparathyroidism | Phase 2 | Status: RECRUITING